Brochure | March 24, 2020

Asahi Oligosynthesizer™

At Asahi Kasei Bioprocess, we bring over a decade of experience to every oligosynthesizer project that we undertake, continually improving our platform as we gain valuable feedback from sponsors and contract manufacturers alike.

This wealth of knowledge allows us to understand that oligonucleotides are a rather unique breed of therapeutic – chemically synthesized, yet much larger in size than classic small molecules. Hence, our engineers employ a hybrid approach when designing manufacturing-scale equipment for oligonucleotides, blending the best of antibody equipment and small molecule equipment design principles together to generate the ideal solution specifically for your oligonucleotide.

access the Brochure!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online